|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
28,810,000 |
Market
Cap: |
432.15(M) |
Last
Volume: |
97,298 |
Avg
Vol: |
0 |
52
Week Range: |
$15 - $15 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile AVEO Pharmaceuticals is a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines for patients with cancer. Co.'s product candidates include: Tivozanib, which is for the treatment of renal cell carcinoma, hepatocellular carcinoma, immunologically cold tumors and cholangiocarcinoma; Ficlatuzumab, which is a humanized immunoglobulin G1 (IgG1) monoclonal antibody that targets hepatocyte growth factor; AV-380, which is a humanized IgG1 monoclonal antibody that targets growth differentiation factor 15; AV-203, which is a humanized IgG1 monoclonal antibody that targets ErbB3; and AV-353, which is a IgG1 monoclonal antibody that targets the Notch 3 pathway.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2023-12-28 |
2023-09-26 |
2023-03-28 |
2022-03-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Bate Kenneth |
Director |
|
2023-01-19 |
4 |
D |
$15.00 |
$5,625 |
D/D |
(375) |
375 |
|
- |
|
Ferraresso Michael |
Chief Commercial Officer |
|
2023-01-19 |
4 |
D |
$15.00 |
$245,175 |
D/D |
(16,345) |
0 |
|
- |
|
Evnin Anthony B |
Director |
|
2023-01-19 |
4 |
D |
$15.00 |
$627,615 |
D/D |
(41,841) |
0 |
|
- |
|
Bailey Michael P |
President & CEO |
|
2023-01-19 |
4 |
D |
$15.00 |
$4,997,505 |
D/D |
(333,167) |
0 |
|
- |
|
Bailey Michael P |
President & CEO |
|
2022-12-20 |
4 |
OE |
$3.67 |
$1,248,144 |
D/D |
276,746 |
340,167 |
|
- |
|
Nea 15 Gp, Llc |
10% Owner |
|
2022-10-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(59,294) |
0 |
|
- |
|
Nea 15 Gp, Llc |
10% Owner |
|
2022-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
59,294 |
59,294 |
|
- |
|
Nea 15 Gp, Llc |
10% Owner |
|
2022-10-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,905,914) |
0 |
|
- |
|
Nea 15 Gp, Llc |
10% Owner |
|
2022-10-19 |
4 |
A |
$0.00 |
$0 |
I/I |
3,952,957 |
3,952,957 |
|
- |
|
Sonsini Peter W. |
10% Owner |
|
2022-10-19 |
4 |
A |
$0.00 |
$0 |
I/I |
4,013,874 |
24 |
|
- |
|
Sonsini Peter W. |
10% Owner |
|
2022-10-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,965,208) |
0 |
|
- |
|
New Enterprise Associates 15, L.p. |
10% Owner |
|
2022-10-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,952,957) |
0 |
|
- |
|
New Enterprise Associates 15, L.p. |
10% Owner |
|
2022-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,952,957 |
3,952,957 |
|
- |
|
New Enterprise Associates 15, L.p. |
10% Owner |
|
2022-10-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,952,957) |
0 |
|
- |
|
Growth Equity Opportunities Fund Iv, Llc |
10% Owner |
|
2022-10-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,952,957) |
0 |
|
- |
|
Florence Anthony A. Jr. |
10% Owner |
|
2022-10-19 |
4 |
A |
$0.00 |
$0 |
I/I |
4,012,605 |
354 |
|
- |
|
Florence Anthony A. Jr. |
10% Owner |
|
2022-10-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,965,208) |
0 |
|
- |
|
Baskett Forest |
10% Owner |
|
2022-10-19 |
4 |
A |
$0.00 |
$0 |
I/I |
4,015,471 |
3,220 |
|
- |
|
Baskett Forest |
10% Owner |
|
2022-10-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,965,208) |
0 |
|
- |
|
Sandell Scott D |
10% Owner |
|
2022-10-19 |
4 |
A |
$0.00 |
$0 |
I/I |
4,015,810 |
386 |
|
- |
|
Sandell Scott D |
10% Owner |
|
2022-10-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,965,208) |
0 |
|
- |
|
Makhzoumi Mohamad |
10% Owner |
|
2022-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
559 |
559 |
|
- |
|
Makhzoumi Mohamad |
10% Owner |
|
2022-10-19 |
4 |
A |
$0.00 |
$0 |
I/I |
4,012,605 |
354 |
|
- |
|
Makhzoumi Mohamad |
10% Owner |
|
2022-10-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,965,208) |
0 |
|
- |
|
Bailey Michael P |
President & CEO |
|
2021-09-01 |
4 |
B |
$6.48 |
$97,200 |
D/D |
15,000 |
49,311 |
2.81 |
-39% |
|
336 Records found
|
|
Page 1 of 14 |
|
|